secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stereotaxis, Inc. (STXS)
CIK:        0001289340
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001493152-24-020281
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stereotaxis acquires APT for stock; earnouts based on revenue & regulatory milestones
--------------------------------------------------------------------------------

- Acquires APT, a diagnostic catheter maker, for stock consideration; earnouts tied to global revenue and US/EU regulatory milestones for robotically-navigated catheters.
- Upfront stock consideration ~6.1M shares (~25% of total); closing expected Q3 2024 subject to APT shareholder approval and debt restructuring.
- APT must pay Stereotaxis a $1.0M termination fee if it breaches non-solicitation restrictions.
- At annual meeting, shareholders re-elected David Fischel, ratified Ernst & Young, approved +4M shares for stock plan and +250K shares for ESPP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1289340/000149315224020281/0001493152-24-020281-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1289340/000149315224020281/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-020281

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer